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Summary
Nicotinic acid adenine dinucleotide phosphate (NAADP)
and cyclic adenosine diphosphate ribose (cADPR)
were first demonstrated to mobilize Ca2+ in sea urchin
eggs [1, 2]. In the absence of direct measurements
of these messengers, pharmacological studies alone
have implicated these molecules as intracellular sec-
ond messengers for specific cell surface receptor ag-
onists [3–7]. We now report that in mouse pancreatic
acinar cells, cholecystokinin, but not acetylcholine,
evokes rapid and transient increases in NAADP levels
in a concentration-dependent manner. In contrast,
both cholecystokinin and acetylcholine-mediated pro-
duction of cADPR followed a very different time course.
The rapid and transient production of NAADP evoked
by cholecystokinin precedes the onset of the Ca2+
signal and is consistent with a role for NAADP in the
initiation of the Ca2+ response [5, 6]. Continued ago-
nist-evoked Ca2+ spiking is maintained by prolonged
elevations of cADPR levels through sensitization of
Ca2+-induced Ca2+-release channels. This study rep-
resents the first direct comparison of NAADP and
cADPR measurements, and the profound differences
observed in their time courses provide evidence in
support of distinct roles of these Ca2+-mobilizing
messengers in shaping specific Ca2+ signals during
agonist stimulation [3–7].
Results and Discussion
A current hypothesis for cholecystokinin signaling in
pancreatic acinar cells, based on physiological data,
proposes that NAADP acts as an initiator of Ca2+ sig-
nals by releasing Ca2+, which then triggers Ca2+-*Correspondence: michiko.yamasaki@pharmacology.oxford.ac.ukinduced Ca2+ release from InsP3 and ryanodine recep-
tors, thereby amplifying the Ca2+ signal [5, 6]. We first
investigated the effect of cholecystokinin on latency to
initiate Ca2+ spiking. The frequency of Ca2+ spikes in-
creases with cholecystokinin concentration (Figure 1A).
In addition, Ca2+ spiking was initiated after a distinct
latency (8.7 ± 1.6 to 34.0 ± 2.5 s, n = 10–27) that was
inversely dependent on the cholecystokinin concentra-
tion (Figures 1A and 1B).
Although the involvement of cADPR in the response
to cholecystokinin has been assumed by its sensitivity
to the selective antagonist, 8-NH2-cADPR, there is no
direct evidence for an increase in cADPR levels. We
next examined the effect of a physiological concentra-
tion of cholecystokinin (10 pM) on cADPR production
over time by employing a radioreceptor assay based
on the sea urchin egg cADPR binding protein [8–11].
The production of cADPR took around 2 min to reach
its maximum and, remarkably, remained elevated for
several minutes (Figure 2A). This effect was essentially
abolished in the presence of cholecystokinin-A recep-
tor antagonist lorglumide (10 M), suggesting a role for
cholecystokinin-A receptors. In addition, cholecysto-
kinin induced an elevation in cADPR levels in a concen-
tration-dependent manner (EC50 = 4.6 ± 2.1 pM, n > 3)
(Figure 2B).
The neurotransmitter acetylcholine, released from the
vagus nerve, acts as an important secretagogue in pan-
creatic acinar cells by activating muscarinic receptors
to also elicit a specific Ca2+ signature [3, 5, 12]. Thus,
we tested whether acetylcholine stimulates cADPR
production. As with cADPR increases in response to
cholecystokinin, cADPR levels peaked at 1–2 min by
the stimulation of 50 nM acetylcholine, a physiologi-
cally relevant concentration, and remained elevated for
several minutes (Figure 3A). However, in the presence
of the muscarinic acetylcholine receptor antagonist at-
ropine (10 M), acetylcholine failed to elevate cADPR
levels (Figure 3A). Acetylcholine generated cADPR in a
concentration-dependent manner (EC50 = 6.3 ± 3.4 nM,
n > 3) (Figure 3B), consistent with previous measure-
ments [13].
Because NAADP has been proposed to evoke a small
localized Ca2+ signal before globalization by Ca2+-
induced Ca2+ release, we reasoned that NAADP should
rise within the latent period observed above. Therefore,
the early time course of NAADP production in response
to cholecystokinin was examined. Figure 4A presents a
single experiment demonstrating the effect of a physio-
logical concentration of cholycystokinin (10 pM) on
NAADP production over time. After application of cho-
lecystokinin at 10 pM, NAADP levels increased approxi-
mately 6-fold on average from a basal level of 0.24 ±
0.08 pmol/mg (Figure 4B, n = 12). The increase in
NAADP was maximal at 5–10 s and returned to resting
levels after approximately 1 min (Figure 4B). This rapid
increase in NAADP level is consistent with the hypothe-
sis that NAADP acts as a trigger to initiate cholecysto-
kinin-evoked Ca2+ signals because it becomes elevated
within the time frame for latencies for the Ca2+ re-
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875Figure 1. The Effect of Different Concentra-
tions of Cholecystokinin on Ca2+ Spiking and
Latencies of the Initial Response
(A) The inset shows that at low concentra-
tions, cholecystokinin induced oscillations.
The frequency of Ca2+ spikes increased with
cholecystokinin concentrations. Over a low
concentration range, cholecystokinin in-
duced oscillations.
(B) Plot illustrating the effect of cholecysto-
kinin concentration on the initial Ca2+ in-
crease over time. Apparent latencies were
reduced in a concentration-dependent man-
ner as cholecystokinin concentrations were
raised (n = 10–27) as also indicated in the
inset table. Data are mean ± SEM.of NAADP in Ca signaling in pancreatic acinar cells in mouse pancreatic acinar cells because it releases
Figure 2. Effect of Cholecystokinin on
cADPR Production
(A) The time course of cADPR production
(closed circles) was determined in the pres-
ence of physiological concentration of cho-
lecystokinin (10 pM). The production of
cADPR took around 2 min to reach its maxi-
mum, remained elevated for several minutes,
and returned to basal levels after around 10
min. The cholecystokinin-A receptor antago-
nist, lorglumide, inhibited cADPR production
(closed triangles).
(B) Cholecystokinin induced increases in
cADPR levels (closed squares) in a concen-
tration-dependent manner. The increase was
4-fold with an EC50 of 4.6 ± 2.1 pM (n > 3).
Data are mean ± SEM.sponses (Figure 1). Having determined that the increase
in NAADP peaked at 5–10 s, we next explored the con-
centration-response relationship between cholecysto-
kinin and NAADP levels. The resulting concentration-
response relationship displayed a shallow slope (Hill
coefficient of 0.3) and extended over approximately five
orders of magnitude and exhibited an inflection point
(Figure 4C). The relationship was best fit to a two-site
model, which yielded an EC50 of 11 ± 3 pM for the high-
affinity site and 830 ± 7 pM for the low-affinity site (Fig-
ure 4C, n = 6–9). Lorglumide (10 M) prevented the
increases in NAADP at all cholecystokinin concentra-
tions, confirming the involvement of the cholecysto-
kinin-A receptor.
In contrast to cholecystokinin, a role for NAADP in
acetylcholine signaling has been considered unlikely
because high inactivating concentrations of NAADP
abolish cholecystokinin but not acetylcholine-induced
Ca2+ spiking [4]. To test the exclusivity of NAADP prod-
uction for cholecystokinin-A receptor activation, we de-
termined the effect of acetylcholine on NAADP prod-
uction. A supramaximal acetylcholine concentration
(1 M) at 5 s after application failed to induce a detect-
able change in NAADP levels (Figure 4D). In the same
series of experiments, a physiological concentration of
cholecystokinin (10 pM) at 5 s after application induced
about a 4-fold elevation of NAADP. These results de-
monstrate receptor-specific coupling to NAADP prod-
uction.
Despite intensive studies into the physiological roles
2+and the common referral to a working model in which
NAADP production is linked to cholecystokinin stimula-
tion [5, 6], direct demonstrations of changes in NAADP
levels in response to agonists has been lacking. We
have now provided the first direct evidence linking cho-
lecystokinin stimulation to NAADP production, thereby
demonstrating that it has the hallmarks of a second
messenger and also demonstrating a basic tenant of
the model. The striking difference in time course be-
tween NAADP and cADPR production in response to
physiological cholecystokinin concentrations is consis-
tent with our previous “trigger” hypothesis [5, 6] that
this agonist, at low physiological concentrations, ini-
tially enhances NAADP production, which would induce
a localized Ca2+ release that then activates cADPR-
sensitized ryanodine receptors, allowing the mainte-
nance of Ca2+ spiking for the duration of agonist stimu-
lation of pancreatic acinar cells.
It has been reported that the endoplasmic reticulum
is continuous in pancreatic acinar cells [14]. However,
previous work on pancreatic acinar cells suggests non-
uniform intracellular distribution of Ca2+-release chan-
nels involved in agonist signaling. Although significant
increases of InsP3 have not been detected in response
to physiological concentration of cholecystokinin [15],
InsP3 receptors are highly concentrated at the apical
pole [3, 16], whereas distribution of ryanodine recep-
tors are homogeneously distributed throughout the cell
[17, 18]. Accumulating studies suggest that NAADP re-
ceptors are more likely concentrated at the apical pole
Current Biology
876Figure 3. Effect of Acetylcholine on cADPR
(A) A physiological concentration of acetyl-
choline (50 nM) caused a 3-fold elevation of
cADPR levels (closed diamonds), which was
prevented by 10 M atropine (open circles)
(n > 3).
(B) Acetylcholine generated cADPR prod-
uction in a concentration-dependent manner
(closed squares) with an EC50 of 6.3 ± 3.4 nM
(n > 3). Individual data points are the
mean ± SEM.Ca2+ at the apical area [7]. Additionally, we have pre- C
mviously suggested that NAADP-sensitive stores in pan-
creatic acinar cells are predominantly acidic, lysosome-
srelated organelles, possibly secretory granules, which
are clustered at the apical pole [7]. The localized in- f
ncrease in Ca2+ at the apical pole in response to chole-
cystokinin requires NAADP to initiate Ca2+ release and m
fis also dependent on local recruitment of both InsP3
and ryanodine receptors at the apical zone through c
apositive feedback via Ca2+-induced Ca2+-release mech-
anisms [5, 6]. As previously reported, however, mito- t
ochondria suppress local positive feedback of Ca2+ [19],
even though InsP3 receptors are highly concentrated at i
sthe apical pole [20]. Our new result indicate that the
subsequent globalization of the Ca2+ signal into baso- i
clateral regions occur as cADPR levels slowly rise and
sensitize ryanodine receptors there [17] to elevations in as an ecto-enzyme requires further explanation [23]. In
Figure 4. Effects of Cholecystokinin and
Acetylcholine on NAADP Production
(A) A single experiment showing the effect
of cholecystokinin (10 pM) on the levels of
NAADP over time (open circles). This sample
showed a rapid increase in endogenous
NAADP levels, demonstrating maximum ele-
vation at 5 s after stimulation.
(B) Average results showing the effect of
cholecystokinin (10 pM) on the levels of
NAADP over time (closed diamonds). The
NAADP levels reached a maximum of about
6-fold from a basal level of 0.24 ± 0.08 pmol/
mg protein and returned to resting levels in
about 60 s (n = 12). Data were normalized to
the maximum obtained with each individual
time-course experiment.
(C) The absolute values of the basal level
and peak are 0.688 ± 0.16 pmol/mg and
6.11 ± 2.03 pmol/mg (n = 6). The data were
fitted to the Hill equation with two sites, giv-
ing EC50s of 11.0 ± 3.0 pM and 830 ± 6.6 pM
(n). Lorglumide, a cholecystokinin-A receptor
antagonist, was present at 10 M (n = 3–6)
(open triangles).
(D) A physiological concentration of chole-
cystokinin (10 pM) caused a significant
NAADP increase at 5 s (asterisk, n = 3, p <
0.05), whereas a supramaximal acetylcholine
(1 M) did not cause significant elevation of
NAADP (n = 3). Data are mean ± SEM.a2+ originating from apical regions while interposed
itochondrial Ca2+ barriers are breached [20].
The changes in cADPR and NAADP levels in re-
ponse to agonists reported here provide a prerequisite
or a better understanding of both the coupling mecha-
isms between receptor activation as well as the enzy-
ology of cellular cADPR and NAADP synthesis. A role
or cGMP has been proposed in the regulation of
ADPR synthesis by ADP-ribosyl cyclases in pancre-
tic acinar cells [21], although several other possibili-
ies exist [22]. Furthermore, there are differences in
pinion as to whether the principal ADP-ribosyl cyclase
nvolved in pancreatic acinar cell cADPR or NAADP
ynthesis is CD38 [13, 21]. Although CD38 has been
mplicated in cADPR synthesis in pancreatic acinar
ells [13], the topological paradox of its major location
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877addition, CD38 has been shown to catalyze the synthe-
sis of NAADP but only in vitro [24]. Our findings and
methodologies reported here may help in answering
such outstanding questions.
In summary, this study provides direct evidence for a
rationale of why multiple Ca2+-mobilizing messengers
are produced in response to a given agonist in that their
different time courses of synthesis may operate to
evoke Ca2+ signals with distinct temporal domains.
Experimental Procedures
Isolation of Pancreatic Acinar Cells
Pancreata were excised from male CD1 mice of between 8–10
weeks old and finely chopped before incubation with 200 units/ml
collagenase for 15 min at 37°C. The digested tissue was then
washed and resuspended to 10 ml with buffer of the following com-
position: 140 mM NaCl, 4.7 mM KCl, 1.1 mM MgCl2, 1 mM CaCl2,
10 mM HEPES, 10 mM glucose (pH 7.2). Protease inhibitor cocktail
tablets (Roche Diagnostics), one tablet per 50 ml, were added into
this solution before use. The suspension was triturated by pipetting
to disrupt the tissue. Supernatant that contained dispersed cells
was collected in a new tube and topped up to 15 ml by adding
fresh buffer. After centrifugation at 800 × g for 3 min at 4°C, the
supernatant was discarded, and the cell pellet was suspended in 6
ml buffer and again triturated in order to further disrupt the tissue.
The suspension was centrifuged again as above. The resulting su-
pernatant was discarded, and the cells were kept in buffer supple-
mented with 1 mM CaCl2 at room temperature on a rocking board
for 30 min before use. Prior to use, the cells were centrifuged at
800 × g for 1 min at 4°C. Supernatant was discarded, and the cells
were suspended in the solution without added protease inhibitors.
Single Cell Ca2+ Imaging
Acinar cells were seeded onto polylysine-coated number 1 glass
coverslips and loaded with 1–5 M fura-2 acetoxymethylester
(fura-2/AM) for 30 min at room temperature. Acinar cells were main-
tained in buffer of the following compositions (in mM): 140 NaCl,
4.7 KCl, 1.1 MgCl2, 1 CaCl2, 10 HEPES, and 10 glucose (pH 7.2).
After the loading period, cells were washed and imaged immedi-
ately. Coverslips were mounted in a static chamber (Harvard Appa-
ratus) on an inverted Zeiss 35 Axiovert microscope and imaged
with a conventional epifluorescence system by using Metafluor
software (Universal Imaging). A fraction of the extracellular medium
was withdrawn from the chamber by pipette, mixed well with a
stock drug solution, and then re-added to the chamber. Cells were
excited alternately with 340 and 380 nm light (emission 510 nm),
and ratio images of clusters were recorded every 3–4 s with a 12-
bit CCD camera (MicroMax; Princeton Instruments, NJ). t = 0 is
the time when cholecystokinin was applied into the chamber. The
latencies reported here are consistent among our experiments but
are overestimates with regard to intrinsic latencies, as previously
reported by localized micropipette-application of agonists [25].
Acid Extraction of NAADP and cADPR from a Population
of Isolated Cells
Pancreatic acinar cells were prepared in the solution detailed
above (with no protease inhibitors). Because the most potent stim-
uli for secretion of cholecystokinin is the presence of partially di-
gested food in the lumen of the duodenum, food was withdrawn
from all the mice used in this study for 6 hr before cell preparations.
Agonists were added by pipette into aliquoted population of cells
to conform with the way in which the latency experiments were
conducted, and the cells were then incubated for the appropriate
time at room temperature. Ice-cold 0.75 M HClO4 was added to
stop reactions. Sonication (Jencons Vibracell at amplitude 60) was
carried out to disrupt the cells, and then the cells were placed on
ice for 15 min. The denatured protein was pelleted by centrifuga-
tion at 9,000 × g for 10 min and stored at −80°C for later analysis.
Supernatant was neutralized with 1 M KHCO3 and vortexed. Cen-
trifugation at 9,000 × g for 10 min was then used to remove the
KClO precipitate. The resulting supernatant was stored at −80°C4for radioreceptor assay analysis. The acid extraction allows 65%
recovery of total NAADP or cADPR determined by extracting a
sample with a known amount of [32P]NAADP and determining
radioactivity recovered and a similar recovery was obtained by
using unlabeled NAADP and a Ca2+-releasing bioassay with sea-
urchin-egg homogenate [11].
NAADP Radioreceptor Assay
Synthesis of [32P]NAADP was carried out in a two-step reaction as
described previously [9]. The [32P]NAADP fraction was then stored
at 4°C for use in the assay. The NAADP binding protein from sea
urchin (Lytechius pictus), which is highly specific for NAADP, was
used [8, 10]. Homogenates of sea urchin eggs were prepared as
described previously [9]. Binding reactions were carried out for 20
min at room temperature. Reactions were initiated by the addition
of 0.5% egg homogenate, 0.25 nM [32P]NAADP, and extract from
pancreatic acinar cells. After 20 min, the reaction was terminated
by rapid filtration (Brandel cell harvester) through GF/B filters with
an ice-cold solution (20 mM HEPES and 500 mM potassium acetate
[pH 7.2]). Bound [32P]NAADP was determined by Cerenkov scintil-
lation counting.
cADPR Radioreceptor Assay
Synthesis of [32P]cADPR was performed as previously described
[9]. [32P]cADPR binding assay was carried out as for the [32P]NAADP
binding assay.
Statistical Analysis
Data are presented as mean ± standard error of the mean. Differ-
ences were determined with either Student’s t test (two means)
or analysis of variance (multiple means). Graphical analysis was
performed with Graphpad and Prizm. Significance was taken as
p < 0.05.
Materials
Radiochemicals were from Amersham Bioscience (UK), and other
chemicals were from Sigma except where indicated. Human NAD
kinase was kindly provided by Dr. Mathias Ziegler, University of
Bergen, Norway.
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